Supriya Lifescience Ltd reports Q2 FY27 revenue of ₹206.30 crore, with operating margin at 22.0%
- Q2 revenue rose 3.2% YoY; EBITDA was ₹45.40 crore and net profit was ₹29.25 crore, versus ₹50.43 crore a year earlier.
- H1 FY27 revenue increased 14.8% YoY to ₹396.04 crore; EBITDA was ₹92.86 crore and net profit ₹53.29 crore.
- Margin pressure reflected product and geographic mix, Ambernath ramp-up costs, and elevated raw-material and solvent prices.
